Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Ferraz

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Neurobiology of Disease|March 16, 2019
Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C diseaseSimon Wheeler, Per Haberkant, Meenakshi Bhardwaj, et al.
Clinical Science (London, England : 1979)|December 19, 2025
HDL protein composition differs between young white European and South Asian men before and after weight gainJack D Beazer, James McLaren, Christina Christoffersen, et al.
Biochimica Et Biophysica Acta|November 19, 2013
Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidosesMaria J Ferraz, Wouter W Kallemeijn, Mina Mirzaian, et al.
Chembiochem : a European Journal of Chemical Biology|August 30, 2021
Xylose-Configured Cyclophellitols as Selective Inhibitors for GlucocerebrosidaseQin Su, Sybrin P Schröder, Lindsey T Lelieveld, et al.
Chembiochem : a European Journal of Chemical Biology|February 1, 2023
Corrigendum: Xylose-Configured Cyclophellitols as Selective Inhibitors for GlucocerebrosidaseQin Su, Sybrin P Schröder, Lindsey T Lelieveld, et al.
Blood Cells, Molecules & Diseases|April 6, 2015
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standardMina Mirzaian, Patrick Wisse, Maria J Ferraz, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2021
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vectorMaria Dahl, Emma M K Smith, Sarah Warsi, et al.
Molecular Genetics and Metabolism|January 12, 2016
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disordersMaria J Ferraz, André R A Marques, Paulo Gaspar, et al.
Chemical Science|September 1, 2023
Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidasesDaniël van der Gracht, Rhianna J Rowland, Véronique Roig-Zamboni, et al.
FEBS Letters|February 23, 2016
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidasesMaria J Ferraz, André R A Marques, Monique D Appelman, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Neurobiology of Disease|March 16, 2019
Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C diseaseSimon Wheeler, Per Haberkant, Meenakshi Bhardwaj, et al.
Clinical Science (London, England : 1979)|December 19, 2025
HDL protein composition differs between young white European and South Asian men before and after weight gainJack D Beazer, James McLaren, Christina Christoffersen, et al.
Biochimica Et Biophysica Acta|November 19, 2013
Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidosesMaria J Ferraz, Wouter W Kallemeijn, Mina Mirzaian, et al.
Chembiochem : a European Journal of Chemical Biology|August 30, 2021
Xylose-Configured Cyclophellitols as Selective Inhibitors for GlucocerebrosidaseQin Su, Sybrin P Schröder, Lindsey T Lelieveld, et al.
Chembiochem : a European Journal of Chemical Biology|February 1, 2023
Corrigendum: Xylose-Configured Cyclophellitols as Selective Inhibitors for GlucocerebrosidaseQin Su, Sybrin P Schröder, Lindsey T Lelieveld, et al.
Blood Cells, Molecules & Diseases|April 6, 2015
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standardMina Mirzaian, Patrick Wisse, Maria J Ferraz, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2021
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vectorMaria Dahl, Emma M K Smith, Sarah Warsi, et al.
Molecular Genetics and Metabolism|January 12, 2016
Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disordersMaria J Ferraz, André R A Marques, Paulo Gaspar, et al.
Chemical Science|September 1, 2023
Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidasesDaniël van der Gracht, Rhianna J Rowland, Véronique Roig-Zamboni, et al.
FEBS Letters|February 23, 2016
Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidasesMaria J Ferraz, André R A Marques, Monique D Appelman, et al.
Pageof 5